Trials / Completed
CompletedNCT00957983
EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether EP-4 receptor antagonist can prevent the headache expected during a Prostaglandin E2 infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BGC20-1531 | oral administration followed by Prostaglandin E2 infusion |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2009-08-13
- Last updated
- 2011-01-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00957983. Inclusion in this directory is not an endorsement.